Emerging Biotech Investment: Strategic Analysis of Private Equity and Venture Capital Funding
An excerpt from GlobalData's latest PharmaSphere report, this whitepaper provides in-depth analysis of the current trends and factors shaping the private equity (PE) and venture capital (VC) segments of the financial industry.
These are expected to have a significant impact on the future of emerging biotechnology companies in the US and globally in mind.
The whitepaper discusses the therapeutic areas attracting noteworthy funding in terms of the volume and value of new and follow-on investments, while GlobalData's analysts provide you with the expert insight you need to help you make informed business decisions in a rapidly changing US healthcare system.
Download to read more.